400-8105-099

xxxxx@300.com

China’s first company to independently mass-produce liquid-metal‑bearing medical CT X‑ray tubes | Pre-sales service hotline: 400-8105-099

Language
- Chinese
- English

China | EN

400-8105-099

xxxxx@300.com

China’s first company to independently mass-produce liquid-metal‑bearing medical CT X‑ray tubes | Pre-sales service hotline: 400-8105-099

Language
- Chinese
- English

CN | EN

News and Updates

Latest updates and exciting news,

Helping you gain a comprehensive understanding of Xinwang Technology.

Good News | Zhisu Technology Honored as a 2022 Beijing Intellectual Property Pilot Unit

2023-01-03

Beijing’s intellectual property pilot and demonstration units are an important component of the city’s efforts to deepen the implementation of its innovation-driven strategy and its capital‑wide intellectual property strategy.

Enterprises specializing in high‑tech, cutting‑edge industries and knowledge‑intensive sectors—key areas of priority development for the city.

A comprehensive assessment is conducted across several dimensions, including intellectual property strategy, research funding allocation, patent output, and the commercialization of intellectual property.

Beijing’s pilot and demonstration units for intellectual property may receive priority access to various specialized IP funding programs, including patent subsidies, patent commercialization support, overseas IP early‑warning services, and emergency assistance.

Furthermore, priority is given to recommending applications for various national intellectual property‑related programs, awards, and honors.

This successful designation as a pilot unit for intellectual property rights also, to a certain extent, underscores Zhisu Technology’s investments and the tangible results achieved in technological innovation, as well as in the creation and application of intellectual property.

The identification and management of pilot and demonstration units for intellectual property constitute an important component of Beijing’s efforts to deepen the implementation of its innovation-driven strategy and its capital‑wide intellectual property strategy.

It aims to help enterprises and public institutions enhance their innovation capabilities and their capacity to create, protect, and leverage intellectual property, foster IP‑strong enterprises, and accelerate the development of a high‑end, sophisticated, and cutting‑edge economic structure.

The review and evaluation process conducted a rigorous, comprehensive assessment of shortlisted enterprises, examining their awareness of intellectual property strategy, their intellectual property management systems, R&D investment, patent generation, and the rate of patent commercialization.

Forge ahead with determination, focusing on technological breakthroughs.

This time, Zhishu Technology has successfully been recognized as a pilot unit for intellectual property, further affirming its strength in the independent innovation and R&D of core vacuum electronic components for CT X-ray tubes, as well as its capability to translate patented technologies into practical applications.

As a key testament to a company’s independent innovation, intellectual property is an essential source for enhancing its core competitiveness.

Since its inception, Zhishu Technology has placed great emphasis on building a robust portfolio of core patents and has vigorously developed key core technologies with independent intellectual property rights.

A full‑service team spanning design, R&D, manufacturing, and sales has been established, holding more than 40 core patents and securing China’s first medical device registration certificate for a liquid‑metal bearing–based X‑ray tube.

We remain committed to innovation at the source and continuously drive breakthroughs in foundational technologies. Leveraging our steadily strengthening capacity for independent innovation, we have achieved rapid growth in the CT tube imaging sector.

Technology Leads, Innovation Drives

The successful designation of Zhisu Technology as a Beijing Intellectual Property Pilot Unit for 2022 is a strong recognition of its technological innovation capabilities and its ability to effectively leverage patents.

At the same time, this will provide greater support for Zhisu Technology’s future development in areas such as intellectual property utilization and market expansion.

Zhisu Technology will continue to pursue R&D and innovation, cultivating core technologies and products with independent intellectual property rights, leveraging its innovative DNA to overcome critical technological bottlenecks.

Exploring greater growth opportunities in the data-intensive healthcare imaging sector.